VivoSim Labs (VIVS) Capital Expenditures (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Capital Expenditures of $13000.0 for Q3 2024, down 51.85% year-over-year from $27000.0 in Q4 2023, and down 51.85% quarter-over-quarter from $27000.0 in Q3 2023.
VivoSim Labs (VIVS) Capital Expenditures (2011 - 2026) Analysis & Trends
VivoSim Labs' Capital Expenditures history runs 14 years deep, the most recent figure standing at $13000.0 for Q3 2024.
- In Q3 2024, Capital Expenditures fell 51.85% year-over-year to $13000.0; the TTM figure through Dec 2025 stood at $13000.0 (changed 0.0% YoY), while the FY2025 annual figure was $13000.0, down 69.05% from the prior year.
- Capital Expenditures for Q3 2024 stood at $13000.0, down from $27000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $194000.0 in Q2 2021, with the low at -$170000.0 in Q1 2023.
- The 5-year median for Capital Expenditures is $41000.0 (2022), against an average of $51846.2.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures soared 310.34% in 2022, then plunged 420.75% in 2023.
- VivoSim Labs' Capital Expenditures stood at $35000.0 in 2020, then surged by 280.0% to $133000.0 in 2021, then plunged by 69.17% to $41000.0 in 2022, then plunged by 34.15% to $27000.0 in 2023, then tumbled by 51.85% to $13000.0 in 2024.
- Business Quant data shows VIVS's Capital Expenditures at $13000.0 in Q3 2024, $27000.0 in Q3 2023, and $15000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23,000.00 |
| Jun 30, 2026 | 23,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2024 | 13,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | -170,000.00 |
| Mar 31, 2023 | -170,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 133,000.00 |
| Dec 31, 2021 | 133,000.00 |